» Articles » PMID: 19043433

Out of the Jaws of Death: PRMT5 Steers P53

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2008 Dec 2
PMID 19043433
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The tumour suppressor p53 triggers either cell-cycle arrest or apoptosis. Now, arginine methylation joins a panoply of other post-translational modifications that regulate p53. PRMT5 mediates p53 methylation, which disposes the cell to arrest rather than death.

Citing Articles

Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.

Watts J, Minden M, Bachiashvili K, Brunner A, Abedin S, Crossman T Ther Adv Hematol. 2024; 15:20406207241275376.

PMID: 39290981 PMC: 11406655. DOI: 10.1177/20406207241275376.


Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.

Song B, Yang P, Zhang S Cancer Commun (Lond). 2024; 44(3):297-360.

PMID: 38311377 PMC: 10958678. DOI: 10.1002/cac2.12520.


Carcinogenesis and Prognostic Utility of Arginine Methylation-Related Genes in Hepatocellular Cancer.

Ali W, Xiao W, Hoang H, Cali V, Kajdacsy-Balla A Curr Issues Mol Biol. 2023; 45(12):9422-9430.

PMID: 38132437 PMC: 10742294. DOI: 10.3390/cimb45120591.


Fission yeast Srr1 and Skb1 promote isochromosome formation at the centromere.

Mongia P, Toyofuku N, Pan Z, Xu R, Kinoshita Y, Oki K Commun Biol. 2023; 6(1):551.

PMID: 37237082 PMC: 10219947. DOI: 10.1038/s42003-023-04925-9.


Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.

Che Y, Liu Y, Yao Y, Hill H, Li Y, Cai Q Blood Cancer J. 2023; 13(1):27.

PMID: 36797243 PMC: 9935633. DOI: 10.1038/s41408-023-00799-6.


References
1.
Chen D, Ma H, Hong H, Koh S, Huang S, Schurter B . Regulation of transcription by a protein methyltransferase. Science. 1999; 284(5423):2174-7. DOI: 10.1126/science.284.5423.2174. View

2.
McBride A, Silver P . State of the arg: protein methylation at arginine comes of age. Cell. 2001; 106(1):5-8. DOI: 10.1016/s0092-8674(01)00423-8. View

3.
Aylon Y, Oren M . Living with p53, dying of p53. Cell. 2007; 130(4):597-600. DOI: 10.1016/j.cell.2007.08.005. View

4.
Levine A, Momand J, Finlay C . The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-6. DOI: 10.1038/351453a0. View

5.
Tang Y, Zhao W, Chen Y, Zhao Y, Gu W . Acetylation is indispensable for p53 activation. Cell. 2008; 133(4):612-26. PMC: 2914560. DOI: 10.1016/j.cell.2008.03.025. View